Cellular and structural bases of chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 163, Issue 6, 2001, Pages 1304-1309

  Saetta, Marina ^b   Turato, Graziella ^b   Maestrelli, Piero ^b   Mapp, Cristina E ^b   Fabbri, Leonardo M ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; DISEASE SEVERITY; EMPHYSEMA; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; LUNG FUNCTION; PRIORITY JOURNAL; REVIEW;

EID: 0034988161     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.163.6.2009116     Document Type: Review

References (51)

1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary
2. The relevance in adults of airflow obstruction, but not of mucous hypersecretion, to mortality from chronic lung disease
3. 1 decline and chronic obstructive pulmonary disease morbidity
4. CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease
5. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease
6. Morphologic changes in the muscular pulmonary arteries: Relationship to cigarette smoking, airway disease and emphysema
7. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis
8. Pathologic changes in the peripheral airways of young cigarette smokers
9. Differences in interleukin-8 and tumour necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma
10. Site and nature of airway obstruction in chronic obstructive lung disease
11. The relations between structural changes in small airways and pulmonary function tests
12. CD8+ T-lymphocytes in the peripheral airways of smokers with chronic obstructive pulmonary disease
13. Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and airflow limitation
14. Loss of alveolar attachments in smokers: An early morphometric correlate of lung function impairment
15. Airflow limitation in chronic bronchitis is associated with T-lymphocyte and macrophage infiltration in the bronchial mucosa
16. Inflammation in bronchial biopsies of subjects with chronic bronchitis: Inverse relationship of CD8+ T lymphocytes with FEV1
17. Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers
18. Upregulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive bronchitis
19. Inflammatory cells in the bronchial glands of smokers with chronic bronchitis
20. Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils
21. Integrin upregulation on sputum neutrophils in smokers with chronic airway obstruction
22. Effects of childhood and adolescence-adulthood respiratory infections in a general population
23. Perforin-independent CD8 T-cell mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha
24. Structural and functional consequences of alveolar cell recognition by CD8+ T lymphocytes in experimental lung disease
25. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema
26. Destructive Index: A measurement of lung parenchymal destruction in smokers
27. Cellular and connective tissue changes in alveolar septal walls in emphysema
28. Centrilobular and panlobular emphysema in smokers: Two distinct morphologic and functional entities
29. Inflammatory cell recruitment in emphysema
30. Severity of airflow limitation is associated with severity of airway inflammation in smokers
31. Bronchoscopic evaluation of severe asthma: Persistent inflammation associated with high dose glucocorticoids
32. The National Institutes of Health intermittent positive-pressure breathing trial: Pathology studies. II. Correlation between morphologic findings, clinical findings, and evidence of expiratory airflow obstruction
33. Chronic obstructive pulmonary disease: A continuing challenge
34. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease
35. Prognostic factors in COPD patients receiving long-term oxygen therapy: Importance of pulmonary artery pressure
36. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease
37. Endothelial dysfunction in pulmonary arteries of patients with mild COPD
38. Chronic obstructive pulmonary disease
39. Airway eosinophilia in chronic bronchitis during exacerbations
40. Eotaxin levels and eosinophils in guinea pig bronchoalveolar lavage fluid are increased at the onset of a viral respiratory infection
41. Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: The role of leukotriene B4
42. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations
43. Effect of smoking cessation on airway inflammation in chronic bronchitis
44. Ongoing inflammation in patients with COPD who do not currently smoke
45. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD
46. Glucocorticoid treatment inhibits apoptosis in human neutrophils
47. Long-term treatment with inhaled budesonide in patients with mild chronic obstructive pulmonary disease who continue smoking
48. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: A randomised controlled trial
49. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial
50. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis
51. Corticosteroid reversibility in COPD is related to features of asthma